MYRIAD GENETICS INC — Director's Dealing 2017

Sep 5, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MYRIAD GENETICS INC (MYGN)
CIK: 0000899923
Period of Report: 2017-09-01

Reporting Person: HENDERSON JOHN T (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-09-01	Common Stock	M	10000	$16.46	Acquired	52524	Direct
2017-09-01	Common Stock	S	10000	$30.3056	Disposed	42524	Direct
2017-09-01	Common Stock	M	10000	$16.46	Acquired	52524	Direct
2017-09-01	Common Stock	S	10000	$30.3003	Disposed	42524	Direct
2017-09-01	Common Stock	M	10000	$16.46	Acquired	52524	Direct
2017-09-01	Common Stock	S	10000	$30.2981	Disposed	42524	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-09-01	Non-Qualified Stock Option (right to buy)	$16.46	M	10000	Disposed	2017-11-15	Common Stock (10000)	Direct
2017-09-01	Non-Qualified Stock Option (right to buy)	$16.46	M	10000	Disposed	2017-11-15	Common Stock (10000)	Direct
2017-09-01	Non-Qualified Stock Option (right to buy)	$16.46	M	10000	Disposed	2017-11-15	Common Stock (10000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	300	Indirect

Footnotes

F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F2: Options vest in full upon completion of one full year of service, generally on the earlier of the first anniversary of the date of grant or the date of the next annual meeting of stockholders.